Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02256930 · ClinicalTrials.gov registry record · Phase 1
Skin Safety Study to Evaluate the Sensitizing Potential in Healthy Volunteers
A Phase 1 study of Healthy Volunteers, sponsored by Maruho North America.
- Completed
- Registry status
- Phase 1
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT02256930: Completed Phase 1 study of Healthy Volunteers, sponsored by Maruho North America.
NCT02256930 is a Phase 1 study of Healthy Volunteers that has completed, run by Maruho North America. The registered enrollment target is 240 participants, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02256930, a Phase 1 study of Healthy Volunteers, has completed, sponsored by Maruho North America.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single center, randomized, controlled, within subject comparison, multiple dose study to determine the sensitization potential of M518101 on normal skin under occlusive patch condition.
Primary Outcome
Drug application site will be evaluated for sign of inflammatory skin response (e.g. erythema, edema, papules)
Conditions Studied
Interventions
- OTHER Saline
- DRUG M518101
- DRUG M518101 Vehicle
- OTHER Sodium lauryl sulfate
Study Locations (1)
New Jersey
- TKL research - Fair Lawn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-08 |
| Phase | Phase 1 |
What the finished NCT02256930 record still lists
NCT02256930 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (50% lower).
The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 4 interventions - of which Saline is the first listed.
NCT02256930 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT02256930 about?
NCT02256930 is a clinical study titled "Skin Safety Study to Evaluate the Sensitizing Potential in Healthy Volunteers". This is a single center, randomized, controlled, within subject comparison, multiple dose study to determine the sensitization potential of M518101 on normal skin under occlusive patch condition.
What is the current status of trial NCT02256930?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 240 participants. The study started on 2014-09. Estimated completion is 2015-08.
What conditions does trial NCT02256930 study?
This clinical trial studies the following conditions: Healthy Volunteers.
What interventions are being tested in trial NCT02256930?
The interventions under investigation include: Saline (OTHER), M518101 (DRUG), M518101 Vehicle (DRUG), Sodium lauryl sulfate (OTHER).
Who is sponsoring clinical trial NCT02256930?
This trial is sponsored by Maruho North America, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02256930 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02256930's enrollment target sits among peer trials
240 41st of 283 higher than 243 of 283 other Healthy Volunteers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Volunteers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
RECRUITING · Phase 1
-
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants
RECRUITING · Phase 1
-
A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
RECRUITING · Phase 1
-
Classroom Break, Cognition, and Fitness in Elementary School Children
RECRUITING · Phase 1
-
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia